Effectiveness over Time of Varicella Vaccine

JAMA

Volumn 291, Issue 7, 2004, Pages 851-855

  Vázquez, Marietta ^a   LaRussa, Philip S ^b   Gershon, Anne A ^b   Niccolai, Linda M ^a   Muehlenbein, Catherine E ^a   Steinberg, Sharon P ^b   Shapiro, Eugene D ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Columbia Univ Coll of Phys/Surgs ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; VIRUS DNA;

ADOLESCENT; ARTICLE; CASE CONTROL STUDY; CHICKENPOX; CHILD; CONTROLLED STUDY; DRUG EFFICACY; EPIDEMIC; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; VACCINATION; VARICELLA ZOSTER VIRUS; ACTIVE IMMUNIZATION; AGE; IMMUNIZATION; IMMUNOLOGY; INFANT; ISOLATION AND PURIFICATION; PRESCHOOL CHILD; STATISTICS; TIME;

ADOLESCENT; AGE FACTORS; CASE-CONTROL STUDIES; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; FEMALE; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNITY, ACTIVE; IMMUNIZATION SCHEDULE; INFANT; MALE; POLYMERASE CHAIN REACTION; TIME FACTORS; VACCINATION;

EID: 10744232752     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.291.7.851     Document Type: Article

References (17)

1. Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T, Isomura S. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet. 1974;2: 1288-1290.
2. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep. 1996;45(RR-11):1-36
3. Vázquez M, LaRussa PS, Gershon AA, Steinberg SP, Freudigman K, Shapiro ED. The effectiveness of the varicella vaccine in clinical practice. N Engl J Med. 2001;344:955-960.
4. Galil K, Lee B, Strine T, et al. Outbreak of varicella at a day-care center despite vaccination. N Engl J Med. 2002;347:1909-1915.
5. Gatil K, Fair E, Mountcastle N, Britz P, Seward J. Younger age at vaccination may increase risk of varicella vaccine failure. J Infed Dis. 2002;186:102-105.
6. Verstraeten T, Jumaan AO, Mullooly JP, et al. A retrospective cohort study of the association of varicella vaccine failure with asthma, steroid use, age at vaccination, and measles-mumps-rubella vaccination. Pediatrics. 2003;112:e98-e103.
7. LaRussa P, Lungu O, Hardy I, Gershon A, Steinberg S, Silverstein S. Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates. J Virol. 1992;66:1016-1020.
8. Orenstein WA, Bernier RH, Hinman AR. Assessing vaccine efficacy in the field: further observations. Epidemiol Rev. 1988;10:212-241.
9. Cornfield J. A method of estimating comparative rates from clinical data: application for cancers of the lung, breast, and cervix. J Natl Cancer Inst. 1950-51; 11:1269-1275.
10. SAS Institute Inc. SAS Online Doc. Version 8. Cary, NC: SAS Institute Inc; 1999.
11. Abramson JH, Gahlinger PM. Computer Programs for Epidemiologists PEPE v. 4.0. Salt Lake City, Utah: Sagebrush Press; 2001:113-118.
12. Breslow NE, Day NE. Statistical Methods in Cancer Research, Vol. 1: The Analysis of Case Control Studies. Lyon, France: World Health Organization; 1980.
13. Gershon AA. Varicella vaccine-are two doses better than one? N Engl J Med. 2002;347:1962-1963.
14. Watson B, Boardman C, Laufer D, et al. Humoral and cell-mediated immune responses in healthy children after one or two doses of varicella vaccine. Clin Infect Dis. 1995;20:316-319.
15. Seward JF, Watson BM, Peterson CIL, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA. 2002;287:606-611.
16. Decline in annual incidence of varicella-selected states, 1990-2001. MMWR Morb Mortal Wkly Rep. 2003;52:884-885.
17. Varicella-related deaths-United States, 2002. MMWR Morb Mortal Wkly Rep. 2003;52:545-547.